What Are GLP-1s Really Doing to Your Body?

GLP-1 medications are everywhere right now — and so is the noise around them. One side calls them a miracle. The other says they're wrecking your metabolism, your gut, and your muscle. Neither version holds up when you actually read the evidence.

In this episode, we look at what these drugs are really doing inside the body. What happens when appetite is switched off for months at a time. Why losing weight and losing strength can happen simultaneously — and what the DXA data from the STEP 1 trial actually showed about lean mass. Why two-thirds of the weight tends to come back after stopping, and what a thoughtful exit plan looks like. Plus two interactions almost nobody warns patients about: what slowed stomach emptying does to oral birth control, and why your anesthesia team needs to know you're on one of these before any procedure.

We also give the benefits their due. The SELECT trial showed a roughly 20 percent reduction in major cardiovascular events in high-risk patients — that's not a cosmetic result, and it deserves to be part of an honest conversation.

Then we turn to the bioregulatory question that sits underneath all of it: is this intervention restoring your body's ability to regulate itself, or is the benefit only holding as long as the drug keeps pressing down? Along the way, we look at emerging research on Akkermansia muciniphila, a gut bacterium that may influence your own GLP-1 signaling from the inside.

The same medication can be rational treatment for one person and a poor biological trade for another. This episode is about knowing which one you are.